Dhruba Chatterjee

Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

David J. Klein, Tadej Battelino, Dhruba Chatterjee et al. · Diabetes Technology & Therapeutics · 2014 · 103 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Absence of QTc Prolongation in a Thorough QT Study With Subcutaneous Liraglutide, a Once‐Daily Human GLP‐1 Analog for Treatment of Type 2 Diabetes

Dhruba Chatterjee, Naum Khutoryansky, Milan Zdravkovic et al. · The Journal of Clinical Pharmacology · 2009 · 54 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Effect of Vehicles and Penetration Enhancers on the In Vitro and In Vivo Percutaneous Absorption of Methotrexate and Edatrexate Through Hairless Mouse Skin

Dhruba Chatterjee, Wen Y. Li, Robert T. Koda · Pharmaceutical Research · 1997 · 48 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

Co‐administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction

Linda Morrow, Marcus Hompesch, H. D. Guthrie et al. · Diabetes Obesity and Metabolism · 2010 · 39 citations

Medicine, Pharmacokinetics, Pharmacology +15

RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes

Shalini Rawat, Dhruba Chatterjee, Rituraj Marwaha et al. · The Journal of Cell Biology · 2022 · 26 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17